Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16958647 | 0.89 | CHRM2 (0.42) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL10981497 | 0.88 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL10980213 | 0.88 | SMN1; SMN2 (0.52) | ALDH1A1L3MBTL1MAPTKDM4EMEN1 | |
| SCHEMBL27436345 | 0.84 | HTR1A (0.56) | ALDH1A1L3MBTL1MAPTLMNAMEN1 | |
| SCHEMBL2068454 | 0.84 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL16959324 | 0.83 | NPSR1 (0.38) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL16955203 | 0.82 | L3MBTL1 (0.39) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL16961864 | 0.82 | MEN1 (0.43) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL16960643 | 0.82 | L3MBTL1 (0.36) | ALDH1A1L3MBTL1MAPTLMNAKDM4E | |
| SCHEMBL973269 | 0.81 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1MAPTKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | claimed |
| EP-2363390-A1 | DERIVED LACTAM FROM D3 VITAMIN | Teijin Pharma Limited (JP) | 2011-09-07 | — | — | EP | claimed |
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | TEIJIN PHARMA LIMITED (JP) | 2011-08-25 | — | — | US | claimed |
| CN-118176259-A | Dispersion of carbon nanotubes, coating liquid composition for electrode using same, electrode, and lithium ion secondary battery | 第一工业制药株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-117866200-A | Polybenzoxazole precursor, process for producing the same, and photosensitive resin composition | 上海交通大学 | 2024-04-12 | — | — | CN | disclosed |
| EP-3575281-B1 | DIAMINE COMPOUND, AND POLYIMIDE COMPOUND AND MOLDED ARTICLE IN WHICH SAID DIAMINE COMPOUND IS USED | WINGO TECH CO LTD (JP) | 2023-08-23 | — | — | EP | disclosed |
| CN-113518792-B | Polybenzoxazole precursor containing ester diamine, photosensitive resin composition, dry film, cured product, and electronic component | 太阳控股株式会社 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023080059-A1 | DISPERSION OF CARBON NANOTUBES, COATING LIQUID COMPOSITION FOR ELECTRODE USING SAME, ELECTRODE, AND LITHIUM ION SECONDARY BATTERY | 第一工業製薬株式会社 | 2023-05-11 | — | — | WO | disclosed |
| CN-111770951-B | Polyimide compound and molded article comprising same | 胜高科技股份有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20220162445-A1 | POLYIMIDE COMPOUND AND MOLDED ARTICLE COMPRISING THE POLYIMIDE COMPOUND | WINGO TECHNOLOGY CO., LTD. (JP) | 2022-05-26 | — | — | US | disclosed |
| EP-3919548-A1 | POLYIMIDE COMPOUND AND MOLDED ARTICLE CONTAINING SAID POLYIMIDE COMPOUND | Wingo Technology Co., Ltd. (JP) | 2021-12-08 | — | — | EP | disclosed |
| US-4864021-A | ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-09-05 | — | — | US | disclosed |
| EP-0323441-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1989-07-05 | — | — | EP | disclosed |
| US-4727073-A | CEREBOVASCULAR DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-02-23 | — | — | US | disclosed |
| US-4678792-A | ANTITHROMBIC AGENTS | DR. KARL THOMAE GMBH (DE) | 1987-07-07 | — | — | US | disclosed |
| EP-0223245-A2 | Curable compositions for dental drugs having sustained release property | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1987-05-27 | — | — | EP | disclosed |
| EP-0180897-A2 | 5-Fluorouracil derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-14 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| EP-0177287-A2 | Pyrimidine derivatives, processes for preparation thereof and composition of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-04-09 | — | — | EP | disclosed |
| US-4497815-A | 1-(N-Substituted carbamoyl)-5-fluorouracil derivatives and the carcinostatic agents containing same as active ingredients | Ozaki, Shoichiro (JP) | 1985-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110207944-A1 | VITAMIN D3 LACTAM DERIVATIVE | VDR, CYP24A1, CYP2R1 | ALDH1A1 1894/4885L3MBTL1 763/4885MAPT 2111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.